Cited by 163Vitamin K Research StudiesBone health and osteoporosis researchVitamin D Research Studies

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Vitamin K Treatment Reduces Undercarboxylated Osteocalcin but Does Not Alter Bone Turnover, Density, or Geometry in Healthy Postmenopausal North American Women

Open access

Abstract

Low vitamin K status is associated with low BMD and increased fracture risk. Additionally, a specific menaquinone, menatetrenone (MK4), may reduce fracture risk. However, whether vitamin K plays a role in the skeletal health of North American women remains unclear. Moreover, various K vitamers (e.g., phylloquinone and MK4) may have differing skeletal effects. The objective of this study was to evaluate the impact of phylloquinone or MK4 treatment on markers of skeletal turnover and BMD in nonosteoporotic, postmenopausal, North American women. In this double-blind, placebo-controlled study, 381 postmenopausal women received phylloquinone (1 mg daily), MK4 (45 mg daily), or placebo for 12 mo. All participants received daily calcium and vitamin D3 supplementation. Serum bone-specific alkaline phosphatase (BSALP) and n-telopeptide of type 1 collagen (NTX) were measured at baseline and 1, 3, 6, and 12 mo. Lumbar spine and proximal femur BMD and proximal femur geometry were measured by DXA at baseline and 6 and 12 mo. At baseline, the three treatment groups did not differ in demographics or study endpoints. Compliance with calcium, phylloquinone, and MK4 treatment was 93%, 93%, and 87%, respectively. Phylloquinone and MK4 treatment reduced serum undercarboxylated osteocalcin but did not alter BSALP or NTX. No effect of phylloquinone or MK4 on lumbar spine or proximal femur BMD or proximal femur geometric parameters was observed. This study does not support a role for vitamin K supplementation in osteoporosis prevention among healthy, postmenopausal, North American women receiving calcium and vitamin D supplementation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1359/jbmr.081254

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 48 references

Research works printed but not linked: 2

  1. Orimo, 1992, Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis-a double-blind multicenter comparative study with 1alpha hydroxyvitamin D, J Bone Miner Res, 7, S122
  2. Gundberg, 1998, Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin, J Clin Endocrinol Metab, 83, 3258

Cited by

Sorted by citations

Metadata

Authors
Binkley, N., Harke, J., Krueger, D., Engelke, J., Vallarta-Ast, N., Gemar, D., Checovich, M., Chappell, R., & Suttie, J.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
Binkley, Neil
Venue
Journal of Bone and Mineral Research
Published
2009-06-01
Volume
24
Issue
6
Pages
983-991
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2040235605
Cited by
163
References
48
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 3 · 2022: 13 · 2021: 4 · 2020: 12 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 11 · 2015: 8 · 2014: 13 · 2013: 11 · 2012: 12
FWCI
11.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eisai
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058363)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
Keywords
vitamin K supplementation, vitamin K1, menatetrenone, vitamin K2, undercarboxylated osteocalcin, bone turnover markers, bone mineral density, bone geometry, postmenopausal women, osteoporosis prevention, fracture risk, bone-specific alkaline phosphatase, calcium and vitamin D supplementation
MeSH terms
Alkaline Phosphatase, Double-Blind Method, Female, Humans, Vitamin K 1, Placebos, Vitamin K, Absorptiometry, Photon, Bone Density, Osteocalcin, Bone Remodeling, Postmenopause, Vitamin K 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review